惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Martin Fowler
Martin Fowler
博客园 - 三生石上(FineUI控件)
WordPress大学
WordPress大学
博客园_首页
宝玉的分享
宝玉的分享
S
SegmentFault 最新的问题
Jina AI
Jina AI
Hugging Face - Blog
Hugging Face - Blog
V
Visual Studio Blog
美团技术团队
IT之家
IT之家
罗磊的独立博客
Blog — PlanetScale
Blog — PlanetScale
Google DeepMind News
Google DeepMind News
月光博客
月光博客
Microsoft Azure Blog
Microsoft Azure Blog
H
Help Net Security
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
Last Week in AI
Last Week in AI
博客园 - 叶小钗
M
MIT News - Artificial intelligence
B
Blog RSS Feed
有赞技术团队
有赞技术团队
Y
Y Combinator Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Galderma Group AG (GALDY) Q1 2026 Sales/Trading Call Tran...
2026-04-24 · via All Articles on Seeking Alpha

Galderma Group AG (GALDY) Q1 2026 Sales/Trading Call April 23, 2026 9:30 AM EDT

Company Participants

Emil Ivanov - Head of Strategy, Investor Relations & ESG
Flemming Ornskov - CEO & Director
Thomas J. Dittrich - Chief Financial Officer

Conference Call Participants

Victor Floch - BNP Paribas, Research Division
Benjamin Jackson - Jefferies LLC, Research Division
Shyam Kotadia - Goldman Sachs Group, Inc., Research Division
Joffrey Meller - BofA Securities, Research Division
Thibault Boutherin - Morgan Stanley, Research Division
Sophia Graeff Buhl Nielsen - JPMorgan Chase & Co, Research Division
Emily Tedbury - Citigroup Inc., Research Division
Natalia Webster - RBC Capital Markets, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to Galderma's Q1 2026 Trading Update Conference Call. [indiscernible] Please be advised that today's conference is being recorded. I would now like to turn the conference over to Emil Ivanov, Head of Strategy, Investor Relations and ESG, to introduce the call. Emil, please go ahead.

Emil Ivanov
Head of Strategy, Investor Relations & ESG

Thank you. Welcome to Galderma's 2026 First Quarter Trading Update Call, which is planned for 45 minutes. As customary, the press release was published at 7:00 a.m. Central European Standard Time today and can be viewed on our corporate website at any time. Today's presentation slides as well as a recording of the webcast will be made available on our website after the call. Please be advised that today's presentation contains forward-looking statements, which should be treated with the appropriate level of caution as detailed on the slide. Let me now introduce today's trading update webcast. Dr. Flemming Ornskov, CEO of Galderma, will provide performance highlights for the first quarter.

Thomas Dittrich, CFO, will then present the trading update and the financial outlook for the full year. Both Flemming and Thomas will be available to answer questions from financial analysts